U.S. Markets closed

AbbVie, Allergan deal a sign of things to come

AbbVie’s $63B deal to buy Allergan may be the first of many in the pharma sector, says Prudential Financial Chief Market Strategist Quincy Krosby, who predicts companies will rush to do deals before a potential change in control in Washington, D.C. Krosby and Stephen Guilfoyle of Sarge986.com speak with Yahoo Finance’s Alexis Christoforous and Brian Sozzi.